Naltrexone exerts a favourable effect on plasma lipids in abstinent patients with alcohol dependence

Alcohol and Alcoholism

Volumn 35, Issue 1, 2000, Pages 91-97

  Budzyński, Jacek ^a   Rybakowski, Janusz ^b   Świa̧tkowski, Maciej ^a   Torliński, Lech ^a   Kłopocka, Maria ^a   Kosmowski, Wojciech ^a   Ziółkowski, Marcin ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LITHIUM CARBONATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NALTREXONE; TRIACYLGLYCEROL;

ABSTINENCE; ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; HUMAN; HYPOLIPEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0343920686     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/35.1.91     Document Type: Article

References (58)

1. Ahlawat, S. K. and Siwach, S. B. (1994) Alcohol and coronary artery disease. International Journal of Cardiology 44, 157-162.
2. Belfrage, P., Berg, B., Hagestrand, I., Nilson-Ehle, P., Tornqvist, H. and Wiebe, T. (1977) Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. European Journal of Clinical Investigation 7, 127-131.
3. Best, E. S., O'Connor, P. and O'Malley, S. S. (1996) Improvement in serum cholesterol with naltrexone and abstinence from alcohol. Alcoholism: Clinical and Experimental Research 20 (Suppl.), 78A.
4. Betteridge, D. J. and Morrell, J. M. (1998) Clinicians' Guide to Lipids and Coronary Heart Disease, pp. 177-198. Chapman & Hall Medical, London.
5. Borzelleca, J. F., Egle, J. L. Jr, Harris, L. S. and Belleville, J. A. (1995) Toxicological evaluation of mu-agonists. Part II: Assessment of toxicity following 30 days of repeated oral dosing of male and female rats with levo-alpha-noracetylmethadol HCl (NorLAAM). Journal of Applied Toxicology 15, 339-355.
6. Brown, S. L. (1996) Lowered serum cholesterol and low mood: the links remain unproved. British Medical Journal 313, 637-638.
7. Bryant, H. U., Story, J. A. and Yim, G. K. (1987) Morphine-induced alterations in plasma and tissue cholesterol levels. Life Sciences 41, 545-554.
8. Bryant, H. U., Story, J. A. and Yim, G. K. (1988a) Assessment of endogenous opioid mediation in stress-induced hypercholesterolemia in the rat. Psychosomatic Medicine 50, 576-585.
9. Bryant, H. U., Kuta, C. C., Story, J. A. and Yim, G. K. (1988b) Stress- and morphine-induced elevations of plasma and tissue cholesterol in mice: reversal by naltrexone. Biochemical Pharmacology 37, 3777-3780.
10. Calandre, P. E., Lopez, R. C. M., Cano, M. D. and Bernal, P. M. (1998) Lipidos, lipoproteinas y apolipoproteinas sericas en epilepticos adultos tratados con carbamacepina, acido valproico o fenitoina. Revista Neurologicas 27, 785-789.
11. Camps, J., Pizzaro, I., Prats, E., La Ville, A., Turner, P. R., Masana, L. and Joven, J. (1994) Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: effect of alcohol intake cessation. Journal of Hepatology 21, 704-709.
12. Casteli, W. P., Abbot, R. D. and McNamara, P. M. (1983) Summary estimates of cholesterol used to predict coronary heart disease. Circulation 67, 730-734.
13. Criqui, M. H. (1998) Triglycerides and cardiovascular disease. A focus on clinical trials. European Heart Journal 19 (Suppl. A), A36-A39.
14. Devenyi, P., Robinson, G. M., Kapur, B. M. and Roncari, D. A. K. (1981) High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease. American Journal of Medicine 71, 589-593.
15. European Atherosclerosis Society (1992) Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutrition and Metabolism in Cardiovascular Disease 2, 113-156.
16. Farnier, M., Bonnefous, F., Debbas, N. and Irvine, A. (1994) Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Archive of Internal Medicine 154, 441-449.
17. Freedman, D. S., Croft, J. B., Anderson, A. J., Byers, T., Jacobsen, S. J., Gruchow, H. W., Walker, J. A. and Barboriak, J. J. (1994) The relation of documented coronary artery disease to levels of total cholesterol and high-density lipoprotein cholesterol. Epidemiology 5, 80-87.
18. Ginsberg, H., Olefsky, J., Farquhar, J. W. and Reaven, G. M. (1974) Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons. Annals of Internal Medicine 80, 143-149.
19. Goldberg, D. M., Hahn, S. E. and Parkes, J. G. (1995) Beyond alcohol: beverage consumption and cardiovascular mortality. Clinica Chimica Acta 237, 155-187.
20. Gordon, D. J. and Rifkind, B. M. (1989) High density lipoprotein - The clinical implications of recent studies. New England Journal of Medicine 132, 1311-1316.
21. Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Jr, Bangdiwala, S. and Tyroler, A. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8-15.
22. Gould, L. A., Rossow, J. E., Santanello, N. C., Heyse, J. F. and Furberg, C. D. (1995) Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 91, 2274-2282.
23. Haffner, S. M., Applebaum-Bowden, D., Wahi, P. W., Hoover, J. J., Warnick, G. R., Albers, J. J. and Hazzard, W. R. (1985) Epidemiological correlates of high-density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Atherosclerosis 5, 169-177.
24. Hagiage, M., Marti, C., Rigaud, D., Senault, C., Fumeron, F., Apfelbaum, M. and Girard-Globa, A. (1992) Effect of a moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subjects compared with normoponderal controls. Metabolism 41, 856-861.
25. Hartung, G. H., Lawrence, S. J., Reeves, R. S. and Foreyt, J. P. (1993) Effect of alcohol and exercise on postprandial lipemia and triglyceride clearance in men. Atherosclerosis 100, 33-40.
26. Hodis, H. N. and Mack, W. J. (1998) Triglyceride-rich lipoproteins and progression of atherosclerosis. European Heart Journal 19 (Suppl. A), A40-A44.
27. Hojnacki, J. L., Cluette-Brown, J. E., Deschenes, R. N., Mulligan, J. J., Osmolski, T. V., Rencricca, N. J. and Barboriak, J. J. (1992) Alcohol produces dose-dependent antiatherogenic and atherogenic plasma lipoprotein responses. Proceedings of the Society of Experimental Biology and Medicine 200, 67-77.
28. International Collaborative Group (1982) Circulating cholesterol level and risk of death from cancer in men aged 40 to 69. Journal of the American Medical Association 248, 2853-2859.
29. Isojarvi, J., Pakarinen, A. J. and Myllyla, V. V. (1993) Serum lipid levels during carbamazepine medication. A prospective study. Archives of Neurology 50, 590-593.
30. Jones, J. (1998) Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia (The CURVES Study). American Journal of Cardiology 81, 582-587.
31. Kervinen, K., Savolainen, M. J. and Kesaniemi, A. (1991) Multiple changes in apolipoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men. Annals of Medicine 23, 407-413.
32. Lamisse, F., Schellenberg, F., Bouyou, E., Delarne, J., Bernard, J. Y. and Conet, C. (1994) Plasma lipids and alcohol consumption in alcoholic men: effect of withdrawal. Alcohol and Alcoholism 29, 25-30.
33. Langer, R. D., Criqui, M. H. and Reed, D. M. (1992) Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 85, 910-915.
34. Law, M. R., Wald, N. J. and Thompson, S. G. (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? British Medical Journal 308, 367-372.
35. Luoma, P. V. (1988) Microsomal enzyme induction, lipoproteins and atherosclerosis. Pharmacology and Toxicology 62, 243-249.
36. Muldoon, M. F. and Manuck, S. B. (1994) Ischemic heart disease and cholesterol. Safety of cholesterol reduction remains in doubt. British Medical Journal 308, 1104-1105.
37. Muldoon, M. F., Manuck, S. B. and Matthews, K. A. (1990) Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal 301, 309-314.
38. Niemela, O., Klajner, F., Orrego, H., Vidins, E., Blendis, L. and Israel, Y. (1987) Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 7, 1210-1214.
39. Nishiwaki, M., Ishikawa, T., Ito, T., Shige, H., Tomiyasu K., Nakajima, K., Kondo, K., Hashimoto, H., Saitoh, K., Manabe, M., Miyajima, E. and Nakamura, H. (1994) Effect of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis 111, 99-109.
40. Nousiainen, U. and Ryhanen, R. (1984) Serum lipids and hepatic microsomal enzymes with special reference to serum cholinesterase in Wistar rats. General Pharmacology 15, 123-127.
41. Ogishima, T., Deguchi, S. and Okuda, K. (1987) Purification and characterization of cholesterol 7 alpha-hydroxylase from rat liver microsomes. Journal of Biological Chemistry 262, 7646-7650.
42. Paassilta, M., Kervinen, K., Rantala, A. O., Savolainen, M. J., Lilja, M., Reunannen, A. and Kesaniemi, Y. A. (1998) Social alcohol consumption and low Lp(a) lipoprotein concentration in middle aged Finnish men: population based study. British Medical Journal 316, 594-595.
43. Patsch, J. R., Miesenbock, G., Hopferwieser, T., Muhlberger, V., Knapp, E., Dunn, K., Gotto, A. M. and Patsch, W. (1992) Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Atherosclerosis and Thrombosis 12, 1336-1345.
44. Pownall, H. J. (1994) Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins. Journal of Lipid Research 35, 2105-2113.
45. Pyörala, K., DeBacker, L., Poole-Wilson, P. and Wood, D. (1994) Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. European Heart Journal 15, 1300-1331.
46. Renaud, S. and De Lorgeril, M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
47. Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B. and Stampfer, M. J. (1991) Prospective study of alcohol consumption and risk of coronary disease in men. Lancer 328, 464-468.
48. Sabesin, S. M., Hawkins, H. L., Kuiken, L. and Ragland, J. B. (1977) Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease. Gastroenterology 72, 510-518.
49. Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
50. Schrott, M. (1998) A multicenter placebo controlled dose ranging study of atorvastatin. Journal of Cardiovascular Pharmacology and Therapeutics 3, 119-124.
51. Seidel, D., Greten, H., Geisen, H. P., Wengeler, H. and Wieland, H. (1972) Further aspects on the characterization of high and very low density lipoproteins in patients with liver disease. European Journal of Clinical Investigation 2, 359-364.
52. Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., MacFarlane, P. W., McKillop, J. H. and Packard, C. J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine 333, 1301-1307.
53. Simon, J. B. and Scheig, R. (1970) Serum cholesterol esterification in liver disease. Importance of lecithin-cholesterol acyltransferase. New England Journal of Medicine 283, 841-846.
54. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. and Witzum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 320, 915-924.
55. Steinberg, D., Petirson, T. A. and Kuller, L. H. (1991) Alcohol and atherosclerosis. Annals of Internal Medicine 114, 967-976.
56. Tollin, C., Ericsson, M., Johnson, O. and Backman, C. (1985) Clearance of triglycerides from the circulation and its relationship to serum lipoproteins: influence of age and sex. Scandinavian Journal of Clinical and Laboratory Investigation 45, 679-684.
57. Wood, D., De Backer, G., Faergeman, O., Mancia, G. and Pyörala, K. (1998) Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140, 199-270.
58. World Health Organization (1992) International Classification of Diseases, 10th edn. World Health Organization. Geneva.